Get In Touch

Investor Relations

Investment Opportunities

GlobeStar Therapeutics Corporation (OTCQB: GSTC), formerly AngioSoma, is a growth-minded company working in the field of neurodegenerative disease.

The prior version of our investor deck can be found below.

Information Sources

GlobeStar is a publicly traded clinical stage biotechnology company with the OTCBB ticker symbol GSTC. The company has a patented formulation of currently available drugs which have been shown, in our formulation, to enhance the quality of life for Multiple Sclerosis patients.

GlobeStar does not provide forward-looking information and will consistently update our website as appropriate. If you would like to reach out to our investor relations department, please contact us below or email

Transfer Agent

Standard Registrar and Transfer Company

440 East 400 South, Suite 200
Salt Lake City, UT 84111

(801) 571-8844 or (801) 596-2150

Legal Counsel

Sonfield & Sonfield,
Attorneys at Law

(Information on OTC Markets)

2500 Wilcrest Drive, Suite 300
Houston, TX 77042


(Information on OTC Markets)

4100 North Sam Houston Pkwy W,
Suite 200-B, Houston, TX 77086
(832) 242-9950